GW is a Cambridge-based biopharmaceutical company that researches and markets cannabinoid medicine for the treatment of LGS and Dravet syndrome.
Your Rating for this listing
Your review is recommended to be at least 140 characters long
Please provide your business email which will be use for claim procedure.
Please provide your verification details which will be used for claim procedure.
Claim request is processed after verification..
Your request has been submitted successfully.